357 related articles for article (PubMed ID: 8827076)
41. Mosaic allelic insulin-like growth factor 2 expression patterns reveal a link between Wilms' tumorigenesis and epigenetic heterogeneity.
Ohlsson R; Cui H; He L; Pfeifer S; Malmikumpu H; Jiang S; Feinberg AP; Hedborg F
Cancer Res; 1999 Aug; 59(16):3889-92. PubMed ID: 10463576
[TBL] [Abstract][Full Text] [Related]
42. Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changes.
Fukuzawa R; Anaka MR; Heathcott RW; McNoe LA; Morison IM; Perlman EJ; Reeve AE
J Pathol; 2008 Aug; 215(4):377-87. PubMed ID: 18484682
[TBL] [Abstract][Full Text] [Related]
43. Human p57(KIP2) defines a new imprinted domain on chromosome 11p but is not a tumour suppressor gene in Wilms tumour.
Taniguchi T; Okamoto K; Reeve AE
Oncogene; 1997 Mar; 14(10):1201-6. PubMed ID: 9121769
[TBL] [Abstract][Full Text] [Related]
44. Loss of imprinting of a paternally expressed transcript, with antisense orientation to KVLQT1, occurs frequently in Beckwith-Wiedemann syndrome and is independent of insulin-like growth factor II imprinting.
Lee MP; DeBaun MR; Mitsuya K; Galonek HL; Brandenburg S; Oshimura M; Feinberg AP
Proc Natl Acad Sci U S A; 1999 Apr; 96(9):5203-8. PubMed ID: 10220444
[TBL] [Abstract][Full Text] [Related]
45. A novel human homologue of yeast nucleosome assembly protein, 65 kb centromeric to the p57KIP2 gene, is biallelically expressed in fetal and adult tissues.
Hu RJ; Lee MP; Johnson LA; Feinberg AP
Hum Mol Genet; 1996 Nov; 5(11):1743-8. PubMed ID: 8923002
[TBL] [Abstract][Full Text] [Related]
46. Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor.
Taniguchi T; Sullivan MJ; Ogawa O; Reeve AE
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2159-63. PubMed ID: 7534414
[TBL] [Abstract][Full Text] [Related]
47. Genomic imprinting in the rat: linkage of Igf2 and H19 genes and opposite parental allele-specific expression during embryogenesis.
Overall M; Bakker M; Spencer J; Parker N; Smith P; Dziadek M
Genomics; 1997 Oct; 45(2):416-20. PubMed ID: 9344669
[TBL] [Abstract][Full Text] [Related]
48. Imprinting, expression, and localisation of DLK1 in Wilms tumours.
Fukuzawa R; Heathcott RW; Morison IM; Reeve AE
J Clin Pathol; 2005 Feb; 58(2):145-50. PubMed ID: 15677533
[TBL] [Abstract][Full Text] [Related]
49. Location of enhancers is essential for the imprinting of H19 and Igf2 genes.
Webber AL; Ingram RS; Levorse JM; Tilghman SM
Nature; 1998 Feb; 391(6668):711-5. PubMed ID: 9490417
[TBL] [Abstract][Full Text] [Related]
50. Increased expression of the insulin-like growth factor-II gene in Wilms' tumor is not dependent on loss of genomic imprinting or loss of heterozygosity.
Wang WH; Duan JX; Vu TH; Hoffman AR
J Biol Chem; 1996 Nov; 271(44):27863-70. PubMed ID: 8910385
[TBL] [Abstract][Full Text] [Related]
51. Altered imprinting of the H19 and insulin-like growth factor II genes in testicular tumors.
Nonomura N; Miki T; Nishimura K; Kanno N; Kojima Y; Okuyama A
J Urol; 1997 May; 157(5):1977-9. PubMed ID: 9112575
[TBL] [Abstract][Full Text] [Related]
52. Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour.
Astuti D; Latif F; Wagner K; Gentle D; Cooper WN; Catchpoole D; Grundy R; Ferguson-Smith AC; Maher ER
Br J Cancer; 2005 Apr; 92(8):1574-80. PubMed ID: 15798773
[TBL] [Abstract][Full Text] [Related]
53. Hypervariable allelic expression patterns of the imprinted IGF2 gene in tumor cells.
He L; Cui H; Walsh C; Mattsson R; Lin W; Anneren G; Pfeifer-Ohlsson S; Ohlsson R
Oncogene; 1998 Jan; 16(1):113-9. PubMed ID: 9467950
[TBL] [Abstract][Full Text] [Related]
54. Multiple genetic abnormalities of 11p15 in Wilms' tumor.
Feinberg AP
Med Pediatr Oncol; 1996 Nov; 27(5):484-9. PubMed ID: 8827078
[TBL] [Abstract][Full Text] [Related]
55. Relaxation of imprinted genes in human cancer.
Rainier S; Johnson LA; Dobry CJ; Ping AJ; Grundy PE; Feinberg AP
Nature; 1993 Apr; 362(6422):747-9. PubMed ID: 8385745
[TBL] [Abstract][Full Text] [Related]
56. Genetic and epigenetic alterations on the short arm of chromosome 11 are involved in a majority of sporadic Wilms' tumours.
Satoh Y; Nakadate H; Nakagawachi T; Higashimoto K; Joh K; Masaki Z; Uozumi J; Kaneko Y; Mukai T; Soejima H
Br J Cancer; 2006 Aug; 95(4):541-7. PubMed ID: 16909133
[TBL] [Abstract][Full Text] [Related]
57. Polymorphic functional imprinting of the human IGF2 gene among individuals, in blood cells, is associated with H19 expression.
Giannoukakis N; Deal C; Paquette J; Kukuvitis A; Polychronakos C
Biochem Biophys Res Commun; 1996 Mar; 220(3):1014-9. PubMed ID: 8607783
[TBL] [Abstract][Full Text] [Related]
58. Epigenetic lesions at the H19 locus in Wilms' tumour patients.
Moulton T; Crenshaw T; Hao Y; Moosikasuwan J; Lin N; Dembitzer F; Hensle T; Weiss L; McMorrow L; Loew T; Kraus W; Gerald W; Tycko B
Nat Genet; 1994 Jul; 7(3):440-7. PubMed ID: 7920666
[TBL] [Abstract][Full Text] [Related]
59. Epigenetic changes at the insulin-like growth factor II/H19 locus in developing kidney is an early event in Wilms tumorigenesis.
Okamoto K; Morison IM; Taniguchi T; Reeve AE
Proc Natl Acad Sci U S A; 1997 May; 94(10):5367-71. PubMed ID: 9144243
[TBL] [Abstract][Full Text] [Related]
60. Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome.
Gicquel C; Rossignol S; Cabrol S; Houang M; Steunou V; Barbu V; Danton F; Thibaud N; Le Merrer M; Burglen L; Bertrand AM; Netchine I; Le Bouc Y
Nat Genet; 2005 Sep; 37(9):1003-7. PubMed ID: 16086014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
